Revisiting clinical trials on glycemic control and cardiovascular risk
نویسنده
چکیده
The most relevant clinical trials, assessing the role of glycemic control in reducing cardiovascular risk, are examined. The UKPDS was the first to address this issue. More recent trials (ACCORD, ADVANCE and VADT) are controversial and evidences did not support that strict glycemic control (reflected by normal glycated hemoglobin) exclusively is sufficient to reduce cardiovascular risk in complicated individuals with long-term type 2 diabetes mellitus. Some possible reasons for controversies are included.
منابع مشابه
Hypoglycemia, Diabetes, and Cardiovascular Events
D iabetes is at epidemic proportions in the U.S. Patients with diabetes are at increased risk for microand macrovascular complications. The benefit of glycemic control in decreasing the risk for microvascular disease is well established. However, the role of glycemic control in decreasing macrovascular complications has been controversial. Several large clinical trials looking at this issue hav...
متن کاملEffects of Paleolithic Diet on Glucose Control in Adults: A Systematic Review and Meta-analysis of Controlled Clinical Trials
Background: Although the results were conflicting, the Paleolithic diet (PD) was proposed to be effective in improvement of metabolic status. We aimed to conduct a systematic review and meta-analysis on the randomized controlled clinical trials (RCTs) evaluating the effects of PD on glycemic markers. Methods: Online databases such as PubMed, Scopus, Web of Science, and Google Scholar were searc...
متن کاملThe Effects of l-arginine Supplementation on Athletic Performance and Risk Factors of Cardiovascular Disease: Review of Current Evidence
Introduction: Due to controversies in different studies about the effects of L-arginine supplementation on athletic performance and cardiovascular risk factors, this study aimed to review the current evidence on the effects of L-arginine supplementation on athletic performance and cardiovascular risk factors. Methods: This study was done to summarize findings from earlier evidence on the effect...
متن کاملImplications of Contemporary Clinical Trials Cardiovascular Clinical Trials in Patients With Diabetes Mellitus Lessons From the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study
Diabetes mellitus is a well-established risk factor for virtually all cardiovascular outcomes, with clinical trials and observational studies demonstrating greater mortality, more myocardial infarctions, and more episodes of heart failure in diabetic than in nondiabetic individuals.1–6 Moreover, diabetes mellitus is often associated with other cardiovascular risk factors, including hypertension...
متن کاملShould patients with type 2 diabetes focus on glycemic control to reduce their cardiovascular risk?
3 very large randomized trials have recently announced their results, massively expanding the evidence base for the efficacy and safety of intensive glycemic control in patients with type 2 diabetes. Taken together, these trials indicate that tight glycemic control is potentially harmful (one of the trials was stopped earlier than planned because of an increased risk of death in patients assign...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Diabetology and Metabolic Syndrome
دوره 1 شماره
صفحات -
تاریخ انتشار 2009